Diabetes News

SEATTLE — Adults with diabetes who used a GLP-1 receptor agonist after undergoing kidney transplantation had a decline in BMI and more stable measures of kidney function than those who did not use a GLP-1, according to a speaker.

SEATTLE — Providers treating people with type 2 diabetes should take a complication-centric approach for determining first-line pharmacotherapy, according to a consensus statement.

SEATTLE — The rate of deaths attributed to vascular complications increased from 2001 to 2020 for adults with diabetes in the U.S., with the rise mainly due to an increase in deaths from diabetic nephropathy, according to a speaker.

SEATTLE — In this video exclusive, Jonathan D. Leffert, MD, talks with Karl Nadolsky, DO, FACE, DABOM, about the drawbacks of using BMI and the importance of addressing weight stigma and bias when diagnosing and treating obesity.

More than 80% of adults with diabetes using continuous glucose monitoring reported at least one instance of needing to stop using their device due to medical care or a device-related problem, according to survey findings.

Dietary patterns focused on eating more whole grains, vegetables, fruits, legumes, nuts and seeds are best for the management of diabetes, according to an updated guideline published in Diabetologia.

A novel endoscopic procedure combined with semaglutide may eliminate the need for insulin while improving glycemic control and metabolic parameters among patients with type 2 diabetes.

Adults with type 2 diabetes and a high thyroid-stimulating hormone level are more likely to develop diabetic retinopathy, and low time in range further increases the risk for diabetic retinopathy, according to study data.

Adults with overweight or obesity and type 2 diabetes achieved a mean weight loss of more than 13% after taking either 10 mg or 15 mg of tirzepatide for 72 weeks, according to topline results from the SURMOUNT-2 trial.

The FDA granted clearance for a stand-alone, wearable insulin delivery pod for adults aged 18 years and older with type 2 diabetes who use basal insulin daily, according to a press release.